CXCR4 antagonists CX549 or AMD3100 reduced microglia activation [7,8] and T cell infiltration in the ischemic hemisphere and facilitated functional recovery in stroke animals [8,9,10]. The gene discussed is CXCR4; the disease is stroke disorder.